Clinically researched bladder health formulations
Stay up to date with our news.
From award wins to clinical milestones, explore how Seipel Group is shaping the future of urinary health through research, partnerships, and proven results.
Subscribe to our Newsletter for periodic news, research and formula information.
Tracey Seipel, co-authored the chapter ‘Lower Urinary Tract Symptoms, Overactive Bladder Syndrome, and Urinary Incontinence (LUTS, OAB and UI)’ with Dr Alexander G. Schauss, University
Built for brands. Backed by clinical science.
IP-protected and fully documented.
Human and in vivo trials, peer-reviewed and published.
GMP-certified, low-allergen, and scalable.
Capsules, bottled, powder or bulk ingredient formats.
Custom formulations to reflect your unique brand.
We’re here to help you bring real bladder and urinary solutions to market.
Whether you’re starting fresh or scaling up, we’ll help you explore licensing, review the clinical data, and connect with our expert team.
Seipel Group Pty Ltd
6 Boon Street, Ashgrove, QLD 4060 Australia
Disclaimer and References
*Schoendorfer et al, BMC-CAM, January, 2018. Research funded by the Australian Federal Government and Seipel Group. **Schloss et al, Phytomedicine, 2021. Research funded by the Queensland State Government and Seipel Group. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat cure or prevent any disease. Not recommended during pregnancy. Consult a physician before use if taking medication. Consumers are cautioned to read all labels and follow all directions. You should always consult with your healthcare practitioner before using this or any such product
